A new study found that 2/3 of patients with type 2 diabetes do not have the disease under control. Because they are not properly managing their blood sugar levels, patients are putting themselves at high risk for serious complications. The study analyzed A1C test scoresa measure of blood glucose control. Using a laboratory database of 157,000 individuals in 39 states during 2003 and 2004, the researchers found that 67% of the participants tested higher than the target set by endocrinologists. The professionals defined glucose control as an A1C level below 6.5. A survey, however, showed that 84% of patients with type 2 diabetes believed that they were properly controlling their blood sugar, even though 61% said that they were unfamiliar with the A1C test. (The findings were presented at a recent meeting of the American Association of Clinical Endocrinologists.)
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs